A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre.

Clicks: 215
ID: 19221
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Pierre is a member of a diverse family of plants known as Menispermaceae. They are famous for a plethora of important biological functions. is a shrub native to the tropical forest zones of West Africa and thrives in deep shade. It is widely cultivated in Cameroun, Sierra Leone, Nigeria, Ghana, and Côte d'Ivoire. is employed in folk medicine as a cure for wounds, fever, coughs, high blood pressure, breast tumor, constipation, and as an aphrodisiac. Phytochemical investigations revealed that the plant is a rich source of secondary metabolites such as annin, alkaloids, saponins, and flavonoids. Pharmacological activities include anti-diabetic, anti-inflammatory, anti-bacterial, anti-viral, anti-malarial, angiogenic, and anxiogenic. Thus, this present review summarizes the phytochemical and nutritional constituents and important biological studies on various crude extracts, fractions, and isolated principles of all morphological organs of .
Reference Key
olorunnisola2017amedicines Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Olorunnisola, Olubukola Sinbad;Fadahunsi, Olumide Samuel;Adegbola, Peter;
Journal medicines (basel, switzerland)
Year 2017
DOI
E50
URL
https://www.mdpi.com/2305-6320/4/3/50
Keywords
bioinformatics ancient dna palaeogenomics d statistics error reduction sequencing error new zealand aotearoa fukuyoa gambierdiscus kermadec islands rangitāhua ciguatera fish poisoning ciguatoxins maitotoxins cost analysis maize grain pics bag phosphine polypropylene bag silo isolation quarantine corona virus epidemic mathematical model public closings reported and unreported cases

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.